nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCB1—ovarian cancer	0.15	1	CbGaD
Probenecid—SLCO1A2—Chlorambucil—ovarian cancer	0.11	0.177	CbGbCtD
Probenecid—ABCC6—Doxorubicin—ovarian cancer	0.0773	0.124	CbGbCtD
Probenecid—ABCC1—Epirubicin—ovarian cancer	0.0429	0.0691	CbGbCtD
Probenecid—ABCC1—Paclitaxel—ovarian cancer	0.0423	0.0681	CbGbCtD
Probenecid—SLC22A7—Docetaxel—ovarian cancer	0.0389	0.0627	CbGbCtD
Probenecid—ABCC3—Doxorubicin—ovarian cancer	0.0371	0.0598	CbGbCtD
Probenecid—ABCC2—Paclitaxel—ovarian cancer	0.0313	0.0504	CbGbCtD
Probenecid—ABCC1—Docetaxel—ovarian cancer	0.0306	0.0493	CbGbCtD
Probenecid—ABCC2—Carboplatin—ovarian cancer	0.0295	0.0475	CbGbCtD
Probenecid—ABCC1—Doxorubicin—ovarian cancer	0.0228	0.0367	CbGbCtD
Probenecid—ABCC2—Docetaxel—ovarian cancer	0.0226	0.0365	CbGbCtD
Probenecid—ABCB1—Topotecan—ovarian cancer	0.0206	0.0332	CbGbCtD
Probenecid—ABCC2—Doxorubicin—ovarian cancer	0.0169	0.0272	CbGbCtD
Probenecid—CYP2C8—Paclitaxel—ovarian cancer	0.0151	0.0243	CbGbCtD
Probenecid—ABCB1—Vinorelbine—ovarian cancer	0.0145	0.0234	CbGbCtD
Probenecid—CYP3A4—Topotecan—ovarian cancer	0.0124	0.0199	CbGbCtD
Probenecid—CYP2C9—Paclitaxel—ovarian cancer	0.0105	0.0169	CbGbCtD
Probenecid—ABCB1—Paclitaxel—ovarian cancer	0.0102	0.0164	CbGbCtD
Probenecid—CYP3A4—Vinorelbine—ovarian cancer	0.0087	0.014	CbGbCtD
Probenecid—ABCB1—Docetaxel—ovarian cancer	0.00738	0.0119	CbGbCtD
Probenecid—CYP3A4—Paclitaxel—ovarian cancer	0.00611	0.00985	CbGbCtD
Probenecid—ABCB1—Doxorubicin—ovarian cancer	0.0055	0.00886	CbGbCtD
Probenecid—Gingival pain—Paclitaxel—ovarian cancer	0.00452	0.0531	CcSEcCtD
Probenecid—CYP3A4—Docetaxel—ovarian cancer	0.00442	0.00712	CbGbCtD
Probenecid—Nephrotic syndrome—Chlorambucil—ovarian cancer	0.00398	0.0468	CcSEcCtD
Probenecid—PANX1—myometrium—ovarian cancer	0.00366	0.0414	CbGeAlD
Probenecid—ABCC11—embryo—ovarian cancer	0.00337	0.0382	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—ovarian cancer	0.0033	0.00531	CbGbCtD
Probenecid—PANX1—decidua—ovarian cancer	0.00271	0.0307	CbGeAlD
Probenecid—PANX1—endometrium—ovarian cancer	0.00257	0.0291	CbGeAlD
Probenecid—PANX1—uterus—ovarian cancer	0.00237	0.0268	CbGeAlD
Probenecid—ABCC11—gonad—ovarian cancer	0.00229	0.0259	CbGeAlD
Probenecid—Anaemia—Altretamine—ovarian cancer	0.00219	0.0257	CcSEcCtD
Probenecid—Leukopenia—Altretamine—ovarian cancer	0.00212	0.0249	CcSEcCtD
Probenecid—ABCC11—female reproductive system—ovarian cancer	0.00205	0.0231	CbGeAlD
Probenecid—SLC16A7—myometrium—ovarian cancer	0.00196	0.0221	CbGeAlD
Probenecid—PANX1—female gonad—ovarian cancer	0.00194	0.022	CbGeAlD
Probenecid—SLC2A9—female reproductive system—ovarian cancer	0.00193	0.0219	CbGeAlD
Probenecid—PANX1—vagina—ovarian cancer	0.00193	0.0218	CbGeAlD
Probenecid—ABCC11—female gonad—ovarian cancer	0.00186	0.021	CbGeAlD
Probenecid—Anorexia—Altretamine—ovarian cancer	0.00184	0.0217	CcSEcCtD
Probenecid—SLC2A9—female gonad—ovarian cancer	0.00176	0.0199	CbGeAlD
Probenecid—PANX1—testis—ovarian cancer	0.00172	0.0195	CbGeAlD
Probenecid—Hepatic necrosis—Paclitaxel—ovarian cancer	0.0017	0.02	CcSEcCtD
Probenecid—Decreased appetite—Altretamine—ovarian cancer	0.00168	0.0198	CcSEcCtD
Probenecid—ABCC11—testis—ovarian cancer	0.00165	0.0187	CbGeAlD
Probenecid—SLC2A9—testis—ovarian cancer	0.00156	0.0177	CbGeAlD
Probenecid—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.00155	0.0182	CcSEcCtD
Probenecid—SLC16A7—uterine cervix—ovarian cancer	0.00152	0.0172	CbGeAlD
Probenecid—SLC16A7—decidua—ovarian cancer	0.00145	0.0164	CbGeAlD
Probenecid—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00138	0.0162	CcSEcCtD
Probenecid—Haemolytic anaemia—Melphalan—ovarian cancer	0.00135	0.0159	CcSEcCtD
Probenecid—Dizziness—Altretamine—ovarian cancer	0.00128	0.015	CcSEcCtD
Probenecid—SLC16A7—gonad—ovarian cancer	0.00128	0.0145	CbGeAlD
Probenecid—SLC16A7—uterus—ovarian cancer	0.00127	0.0144	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.00126	0.0148	CcSEcCtD
Probenecid—PANX1—lymph node—ovarian cancer	0.00125	0.0141	CbGeAlD
Probenecid—Vomiting—Altretamine—ovarian cancer	0.00123	0.0145	CcSEcCtD
Probenecid—SLC10A1—gonad—ovarian cancer	0.00119	0.0135	CbGeAlD
Probenecid—Nausea—Altretamine—ovarian cancer	0.00115	0.0135	CcSEcCtD
Probenecid—Pain—Carboplatin—ovarian cancer	0.00114	0.0134	CcSEcCtD
Probenecid—SLC16A7—female reproductive system—ovarian cancer	0.00114	0.0129	CbGeAlD
Probenecid—SLC2A9—lymph node—ovarian cancer	0.00113	0.0128	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00107	0.0126	CcSEcCtD
Probenecid—SLC10A1—female reproductive system—ovarian cancer	0.00107	0.0121	CbGeAlD
Probenecid—ABCC5—uterine cervix—ovarian cancer	0.00107	0.0121	CbGeAlD
Probenecid—Body temperature increased—Carboplatin—ovarian cancer	0.00106	0.0124	CcSEcCtD
Probenecid—SLC16A7—vagina—ovarian cancer	0.00103	0.0117	CbGeAlD
Probenecid—ABCC5—decidua—ovarian cancer	0.00102	0.0115	CbGeAlD
Probenecid—SLC16A1—epithelium—ovarian cancer	0.000978	0.0111	CbGeAlD
Probenecid—SLC22A11—female reproductive system—ovarian cancer	0.000973	0.011	CbGeAlD
Probenecid—SLC16A1—decidua—ovarian cancer	0.000924	0.0104	CbGeAlD
Probenecid—SLC16A7—testis—ovarian cancer	0.000921	0.0104	CbGeAlD
Probenecid—Erythema multiforme—Chlorambucil—ovarian cancer	0.000914	0.0108	CcSEcCtD
Probenecid—SLC16A1—endometrium—ovarian cancer	0.000877	0.00992	CbGeAlD
Probenecid—SLC10A1—testis—ovarian cancer	0.00086	0.00973	CbGeAlD
Probenecid—Alopecia—Chlorambucil—ovarian cancer	0.000854	0.01	CcSEcCtD
Probenecid—ABCC3—decidua—ovarian cancer	0.000853	0.00964	CbGeAlD
Probenecid—SLC16A1—gonad—ovarian cancer	0.000813	0.0092	CbGeAlD
Probenecid—ABCC1—myometrium—ovarian cancer	0.000809	0.00915	CbGeAlD
Probenecid—SLCO1C1—testis—ovarian cancer	0.000809	0.00915	CbGeAlD
Probenecid—SLC16A1—uterus—ovarian cancer	0.000808	0.00914	CbGeAlD
Probenecid—Flushing—Melphalan—ovarian cancer	0.000782	0.0092	CcSEcCtD
Probenecid—Anaemia—Chlorambucil—ovarian cancer	0.000778	0.00915	CcSEcCtD
Probenecid—SLC22A7—testis—ovarian cancer	0.000767	0.00867	CbGeAlD
Probenecid—Alopecia—Topotecan—ovarian cancer	0.00076	0.00894	CcSEcCtD
Probenecid—ABCC5—bone marrow—ovarian cancer	0.000754	0.00853	CbGeAlD
Probenecid—Leukopenia—Chlorambucil—ovarian cancer	0.000753	0.00886	CcSEcCtD
Probenecid—Alopecia—Melphalan—ovarian cancer	0.000745	0.00876	CcSEcCtD
Probenecid—ABCC5—female gonad—ovarian cancer	0.000726	0.00822	CbGeAlD
Probenecid—SLC16A1—female reproductive system—ovarian cancer	0.000726	0.00822	CbGeAlD
Probenecid—ABCC5—vagina—ovarian cancer	0.000722	0.00817	CbGeAlD
Probenecid—SLC22A5—myometrium—ovarian cancer	0.000712	0.00805	CbGeAlD
Probenecid—Anaemia—Topotecan—ovarian cancer	0.000692	0.00814	CcSEcCtD
Probenecid—Flushing—Vinorelbine—ovarian cancer	0.000683	0.00804	CcSEcCtD
Probenecid—Anaemia—Melphalan—ovarian cancer	0.000678	0.00797	CcSEcCtD
Probenecid—Leukopenia—Topotecan—ovarian cancer	0.000671	0.00789	CcSEcCtD
Probenecid—ABCC3—female reproductive system—ovarian cancer	0.00067	0.00758	CbGeAlD
Probenecid—SLC16A7—lymph node—ovarian cancer	0.000668	0.00755	CbGeAlD
Probenecid—SLC16A1—female gonad—ovarian cancer	0.000661	0.00748	CbGeAlD
Probenecid—Leukopenia—Melphalan—ovarian cancer	0.000657	0.00772	CcSEcCtD
Probenecid—Anorexia—Chlorambucil—ovarian cancer	0.000655	0.0077	CcSEcCtD
Probenecid—Alopecia—Vinorelbine—ovarian cancer	0.00065	0.00765	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.000644	0.00758	CcSEcCtD
Probenecid—ABCC5—testis—ovarian cancer	0.000644	0.00729	CbGeAlD
Probenecid—ABCC1—uterine cervix—ovarian cancer	0.00063	0.00712	CbGeAlD
Probenecid—ABCC4—uterus—ovarian cancer	0.000616	0.00696	CbGeAlD
Probenecid—Anaphylactic shock—Topotecan—ovarian cancer	0.000611	0.00719	CcSEcCtD
Probenecid—ABCC3—female gonad—ovarian cancer	0.00061	0.0069	CbGeAlD
Probenecid—ABCC1—decidua—ovarian cancer	0.0006	0.00679	CbGeAlD
Probenecid—Anaphylactic shock—Melphalan—ovarian cancer	0.000599	0.00704	CcSEcCtD
Probenecid—Decreased appetite—Chlorambucil—ovarian cancer	0.000597	0.00702	CcSEcCtD
Probenecid—Anaemia—Vinorelbine—ovarian cancer	0.000592	0.00697	CcSEcCtD
Probenecid—Pain—Chlorambucil—ovarian cancer	0.000587	0.00691	CcSEcCtD
Probenecid—SLC16A1—testis—ovarian cancer	0.000586	0.00663	CbGeAlD
Probenecid—SLCO1C1—lymph node—ovarian cancer	0.000586	0.00663	CbGeAlD
Probenecid—Anorexia—Topotecan—ovarian cancer	0.000583	0.00685	CcSEcCtD
Probenecid—Leukopenia—Vinorelbine—ovarian cancer	0.000574	0.00675	CcSEcCtD
Probenecid—Pollakiuria—Paclitaxel—ovarian cancer	0.000571	0.00672	CcSEcCtD
Probenecid—Anorexia—Melphalan—ovarian cancer	0.000571	0.00671	CcSEcCtD
Probenecid—ABCC1—endometrium—ovarian cancer	0.00057	0.00644	CbGeAlD
Probenecid—SLC22A5—uterine cervix—ovarian cancer	0.000554	0.00627	CbGeAlD
Probenecid—ABCC4—female reproductive system—ovarian cancer	0.000553	0.00626	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000547	0.00643	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.000546	0.00643	CcSEcCtD
Probenecid—Urticaria—Chlorambucil—ovarian cancer	0.000546	0.00642	CcSEcCtD
Probenecid—Body temperature increased—Chlorambucil—ovarian cancer	0.000543	0.00639	CcSEcCtD
Probenecid—ABCC3—testis—ovarian cancer	0.000541	0.00612	CbGeAlD
Probenecid—SLC22A1—vagina—ovarian cancer	0.00054	0.00611	CbGeAlD
Probenecid—ABCC2—female reproductive system—ovarian cancer	0.000536	0.00606	CbGeAlD
Probenecid—Decreased appetite—Topotecan—ovarian cancer	0.000531	0.00625	CcSEcCtD
Probenecid—Aplastic anaemia—Epirubicin—ovarian cancer	0.000529	0.00623	CcSEcCtD
Probenecid—Haematuria—Paclitaxel—ovarian cancer	0.000526	0.00619	CcSEcCtD
Probenecid—ABCC1—uterus—ovarian cancer	0.000525	0.00594	CbGeAlD
Probenecid—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000523	0.00615	CcSEcCtD
Probenecid—Pain—Topotecan—ovarian cancer	0.000523	0.00615	CcSEcCtD
Probenecid—ABCC4—bone marrow—ovarian cancer	0.000522	0.00591	CbGeAlD
Probenecid—Decreased appetite—Melphalan—ovarian cancer	0.00052	0.00612	CcSEcCtD
Probenecid—Pain—Melphalan—ovarian cancer	0.000512	0.00602	CcSEcCtD
Probenecid—Hypersensitivity—Chlorambucil—ovarian cancer	0.000506	0.00595	CcSEcCtD
Probenecid—ABCC4—female gonad—ovarian cancer	0.000504	0.0057	CbGeAlD
Probenecid—SLC22A5—endometrium—ovarian cancer	0.000501	0.00567	CbGeAlD
Probenecid—Anorexia—Vinorelbine—ovarian cancer	0.000499	0.00586	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00049	0.00576	CcSEcCtD
Probenecid—Pruritus—Chlorambucil—ovarian cancer	0.000486	0.00572	CcSEcCtD
Probenecid—Urticaria—Topotecan—ovarian cancer	0.000486	0.00571	CcSEcCtD
Probenecid—CYP2C8—endometrium—ovarian cancer	0.000485	0.00549	CbGeAlD
Probenecid—Body temperature increased—Topotecan—ovarian cancer	0.000483	0.00568	CcSEcCtD
Probenecid—Urticaria—Melphalan—ovarian cancer	0.000476	0.00559	CcSEcCtD
Probenecid—Erythema multiforme—Paclitaxel—ovarian cancer	0.000468	0.00551	CcSEcCtD
Probenecid—ABCC5—lymph node—ovarian cancer	0.000467	0.00528	CbGeAlD
Probenecid—SLCO1A2—testis—ovarian cancer	0.000464	0.00525	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000463	0.00545	CcSEcCtD
Probenecid—ALB—testis—ovarian cancer	0.000461	0.00522	CbGeAlD
Probenecid—Flushing—Paclitaxel—ovarian cancer	0.00046	0.00541	CcSEcCtD
Probenecid—Decreased appetite—Vinorelbine—ovarian cancer	0.000455	0.00535	CcSEcCtD
Probenecid—Hypersensitivity—Topotecan—ovarian cancer	0.00045	0.0053	CcSEcCtD
Probenecid—Pain—Vinorelbine—ovarian cancer	0.000447	0.00526	CcSEcCtD
Probenecid—ABCC4—testis—ovarian cancer	0.000447	0.00505	CbGeAlD
Probenecid—Hypersensitivity—Melphalan—ovarian cancer	0.000441	0.00519	CcSEcCtD
Probenecid—Alopecia—Paclitaxel—ovarian cancer	0.000438	0.00515	CcSEcCtD
Probenecid—Vomiting—Chlorambucil—ovarian cancer	0.000437	0.00514	CcSEcCtD
Probenecid—Pruritus—Topotecan—ovarian cancer	0.000433	0.00509	CcSEcCtD
Probenecid—ABCC2—testis—ovarian cancer	0.000432	0.00489	CbGeAlD
Probenecid—ABCC1—female gonad—ovarian cancer	0.000429	0.00486	CbGeAlD
Probenecid—ABCC1—vagina—ovarian cancer	0.000427	0.00483	CbGeAlD
Probenecid—SLC16A1—lymph node—ovarian cancer	0.000425	0.00481	CbGeAlD
Probenecid—Pruritus—Melphalan—ovarian cancer	0.000424	0.00498	CcSEcCtD
Probenecid—CYP2C19—vagina—ovarian cancer	0.000416	0.00471	CbGeAlD
Probenecid—Urticaria—Vinorelbine—ovarian cancer	0.000415	0.00489	CcSEcCtD
Probenecid—SLC22A5—female reproductive system—ovarian cancer	0.000415	0.00469	CbGeAlD
Probenecid—Body temperature increased—Vinorelbine—ovarian cancer	0.000413	0.00486	CcSEcCtD
Probenecid—Nausea—Chlorambucil—ovarian cancer	0.000408	0.0048	CcSEcCtD
Probenecid—Dizziness—Topotecan—ovarian cancer	0.000404	0.00476	CcSEcCtD
Probenecid—CYP2C8—female reproductive system—ovarian cancer	0.000402	0.00454	CbGeAlD
Probenecid—Anaemia—Paclitaxel—ovarian cancer	0.000398	0.00469	CcSEcCtD
Probenecid—Erythema multiforme—Docetaxel—ovarian cancer	0.000397	0.00467	CcSEcCtD
Probenecid—ABCC3—lymph node—ovarian cancer	0.000392	0.00444	CbGeAlD
Probenecid—Flushing—Docetaxel—ovarian cancer	0.000389	0.00458	CcSEcCtD
Probenecid—Vomiting—Topotecan—ovarian cancer	0.000389	0.00457	CcSEcCtD
Probenecid—Leukopenia—Paclitaxel—ovarian cancer	0.000386	0.00454	CcSEcCtD
Probenecid—Hypersensitivity—Vinorelbine—ovarian cancer	0.000385	0.00453	CcSEcCtD
Probenecid—Dermatitis—Topotecan—ovarian cancer	0.000385	0.00453	CcSEcCtD
Probenecid—Headache—Topotecan—ovarian cancer	0.000383	0.00451	CcSEcCtD
Probenecid—ABCC1—testis—ovarian cancer	0.000381	0.00431	CbGeAlD
Probenecid—Vomiting—Melphalan—ovarian cancer	0.000381	0.00448	CcSEcCtD
Probenecid—SLC22A5—female gonad—ovarian cancer	0.000378	0.00427	CbGeAlD
Probenecid—Dermatitis—Melphalan—ovarian cancer	0.000377	0.00444	CcSEcCtD
Probenecid—SLC22A5—vagina—ovarian cancer	0.000375	0.00425	CbGeAlD
Probenecid—Alopecia—Docetaxel—ovarian cancer	0.000371	0.00436	CcSEcCtD
Probenecid—Pruritus—Vinorelbine—ovarian cancer	0.00037	0.00435	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000368	0.00433	CcSEcCtD
Probenecid—CYP2C8—vagina—ovarian cancer	0.000363	0.00411	CbGeAlD
Probenecid—Nausea—Topotecan—ovarian cancer	0.000363	0.00427	CcSEcCtD
Probenecid—CYP2C9—female reproductive system—ovarian cancer	0.000357	0.00404	CbGeAlD
Probenecid—Nausea—Melphalan—ovarian cancer	0.000356	0.00418	CcSEcCtD
Probenecid—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000352	0.00414	CcSEcCtD
Probenecid—Dizziness—Vinorelbine—ovarian cancer	0.000346	0.00407	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000341	0.00401	CcSEcCtD
Probenecid—Anaemia—Docetaxel—ovarian cancer	0.000338	0.00397	CcSEcCtD
Probenecid—Anorexia—Paclitaxel—ovarian cancer	0.000335	0.00394	CcSEcCtD
Probenecid—SLC22A5—testis—ovarian cancer	0.000335	0.00379	CbGeAlD
Probenecid—ALB—lymph node—ovarian cancer	0.000334	0.00378	CbGeAlD
Probenecid—Vomiting—Vinorelbine—ovarian cancer	0.000333	0.00391	CcSEcCtD
Probenecid—ABCB1—myometrium—ovarian cancer	0.00033	0.00374	CbGeAlD
Probenecid—Dermatitis—Vinorelbine—ovarian cancer	0.000329	0.00388	CcSEcCtD
Probenecid—Headache—Vinorelbine—ovarian cancer	0.000328	0.00385	CcSEcCtD
Probenecid—Leukopenia—Docetaxel—ovarian cancer	0.000327	0.00385	CcSEcCtD
Probenecid—Pollakiuria—Epirubicin—ovarian cancer	0.000327	0.00384	CcSEcCtD
Probenecid—CYP2C8—testis—ovarian cancer	0.000324	0.00367	CbGeAlD
Probenecid—ABCC4—lymph node—ovarian cancer	0.000324	0.00366	CbGeAlD
Probenecid—ABCB1—embryo—ovarian cancer	0.000318	0.00359	CbGeAlD
Probenecid—ABCC2—lymph node—ovarian cancer	0.000313	0.00354	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000313	0.00368	CcSEcCtD
Probenecid—Nausea—Vinorelbine—ovarian cancer	0.000311	0.00365	CcSEcCtD
Probenecid—Decreased appetite—Paclitaxel—ovarian cancer	0.000306	0.0036	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—ovarian cancer	0.000302	0.00356	CcSEcCtD
Probenecid—Pain—Paclitaxel—ovarian cancer	0.000301	0.00354	CcSEcCtD
Probenecid—Haematuria—Epirubicin—ovarian cancer	0.000301	0.00354	CcSEcCtD
Probenecid—Anaphylactic shock—Docetaxel—ovarian cancer	0.000298	0.00351	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000289	0.0034	CcSEcCtD
Probenecid—Anorexia—Docetaxel—ovarian cancer	0.000284	0.00334	CcSEcCtD
Probenecid—Urticaria—Paclitaxel—ovarian cancer	0.000279	0.00329	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—ovarian cancer	0.000278	0.00327	CcSEcCtD
Probenecid—Body temperature increased—Paclitaxel—ovarian cancer	0.000278	0.00327	CcSEcCtD
Probenecid—ABCC1—lymph node—ovarian cancer	0.000276	0.00312	CbGeAlD
Probenecid—CYP3A4—female reproductive system—ovarian cancer	0.000272	0.00308	CbGeAlD
Probenecid—Erythema multiforme—Epirubicin—ovarian cancer	0.000268	0.00315	CcSEcCtD
Probenecid—Flushing—Epirubicin—ovarian cancer	0.000263	0.00309	CcSEcCtD
Probenecid—ABCB1—epithelium—ovarian cancer	0.000259	0.00293	CbGeAlD
Probenecid—Decreased appetite—Docetaxel—ovarian cancer	0.000259	0.00305	CcSEcCtD
Probenecid—Hypersensitivity—Paclitaxel—ovarian cancer	0.000259	0.00305	CcSEcCtD
Probenecid—ABCB1—uterine cervix—ovarian cancer	0.000257	0.00291	CbGeAlD
Probenecid—Pain—Docetaxel—ovarian cancer	0.000255	0.003	CcSEcCtD
Probenecid—Alopecia—Epirubicin—ovarian cancer	0.00025	0.00294	CcSEcCtD
Probenecid—Pruritus—Paclitaxel—ovarian cancer	0.000249	0.00293	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—ovarian cancer	0.000248	0.00291	CcSEcCtD
Probenecid—ABCB1—decidua—ovarian cancer	0.000245	0.00277	CbGeAlD
Probenecid—Flushing—Doxorubicin—ovarian cancer	0.000243	0.00286	CcSEcCtD
Probenecid—SLC22A5—lymph node—ovarian cancer	0.000243	0.00275	CbGeAlD
Probenecid—Body temperature increased—Docetaxel—ovarian cancer	0.000236	0.00277	CcSEcCtD
Probenecid—Dizziness—Paclitaxel—ovarian cancer	0.000233	0.00274	CcSEcCtD
Probenecid—ABCB1—endometrium—ovarian cancer	0.000233	0.00263	CbGeAlD
Probenecid—Alopecia—Doxorubicin—ovarian cancer	0.000231	0.00272	CcSEcCtD
Probenecid—Anaemia—Epirubicin—ovarian cancer	0.000228	0.00268	CcSEcCtD
Probenecid—Vomiting—Paclitaxel—ovarian cancer	0.000224	0.00263	CcSEcCtD
Probenecid—Dermatitis—Paclitaxel—ovarian cancer	0.000222	0.00261	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—ovarian cancer	0.000221	0.00259	CcSEcCtD
Probenecid—Headache—Paclitaxel—ovarian cancer	0.00022	0.00259	CcSEcCtD
Probenecid—Hypersensitivity—Docetaxel—ovarian cancer	0.00022	0.00258	CcSEcCtD
Probenecid—ABCB1—gonad—ovarian cancer	0.000216	0.00244	CbGeAlD
Probenecid—ABCB1—uterus—ovarian cancer	0.000214	0.00242	CbGeAlD
Probenecid—Pruritus—Docetaxel—ovarian cancer	0.000211	0.00248	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—ovarian cancer	0.000211	0.00248	CcSEcCtD
Probenecid—Nausea—Paclitaxel—ovarian cancer	0.000209	0.00246	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—ovarian cancer	0.000204	0.0024	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—ovarian cancer	0.000201	0.00237	CcSEcCtD
Probenecid—Dizziness—Docetaxel—ovarian cancer	0.000197	0.00232	CcSEcCtD
Probenecid—ABCB1—female reproductive system—ovarian cancer	0.000193	0.00218	CbGeAlD
Probenecid—Anorexia—Epirubicin—ovarian cancer	0.000192	0.00225	CcSEcCtD
Probenecid—Vomiting—Docetaxel—ovarian cancer	0.00019	0.00223	CcSEcCtD
Probenecid—Dermatitis—Docetaxel—ovarian cancer	0.000188	0.00221	CcSEcCtD
Probenecid—Headache—Docetaxel—ovarian cancer	0.000187	0.0022	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000186	0.00219	CcSEcCtD
Probenecid—ABCB1—bone marrow—ovarian cancer	0.000182	0.00206	CbGeAlD
Probenecid—Anorexia—Doxorubicin—ovarian cancer	0.000177	0.00209	CcSEcCtD
Probenecid—Nausea—Docetaxel—ovarian cancer	0.000177	0.00208	CcSEcCtD
Probenecid—ABCB1—female gonad—ovarian cancer	0.000175	0.00198	CbGeAlD
Probenecid—Decreased appetite—Epirubicin—ovarian cancer	0.000175	0.00206	CcSEcCtD
Probenecid—ABCB1—vagina—ovarian cancer	0.000174	0.00197	CbGeAlD
Probenecid—Pain—Epirubicin—ovarian cancer	0.000172	0.00202	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—ovarian cancer	0.000162	0.0019	CcSEcCtD
Probenecid—Urticaria—Epirubicin—ovarian cancer	0.00016	0.00188	CcSEcCtD
Probenecid—Pain—Doxorubicin—ovarian cancer	0.000159	0.00187	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—ovarian cancer	0.000159	0.00187	CcSEcCtD
Probenecid—ABCB1—testis—ovarian cancer	0.000155	0.00176	CbGeAlD
Probenecid—Hypersensitivity—Epirubicin—ovarian cancer	0.000148	0.00174	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—ovarian cancer	0.000148	0.00174	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—ovarian cancer	0.000147	0.00173	CcSEcCtD
Probenecid—Pruritus—Epirubicin—ovarian cancer	0.000142	0.00167	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—ovarian cancer	0.000137	0.00161	CcSEcCtD
Probenecid—Dizziness—Epirubicin—ovarian cancer	0.000133	0.00156	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—ovarian cancer	0.000132	0.00155	CcSEcCtD
Probenecid—Vomiting—Epirubicin—ovarian cancer	0.000128	0.0015	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—ovarian cancer	0.000127	0.00149	CcSEcCtD
Probenecid—Headache—Epirubicin—ovarian cancer	0.000126	0.00148	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—ovarian cancer	0.000123	0.00145	CcSEcCtD
Probenecid—Nausea—Epirubicin—ovarian cancer	0.000119	0.00141	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—ovarian cancer	0.000118	0.00139	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—ovarian cancer	0.000117	0.00138	CcSEcCtD
Probenecid—Headache—Doxorubicin—ovarian cancer	0.000117	0.00137	CcSEcCtD
Probenecid—ABCB1—lymph node—ovarian cancer	0.000113	0.00127	CbGeAlD
Probenecid—Nausea—Doxorubicin—ovarian cancer	0.000111	0.0013	CcSEcCtD
Probenecid—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.15e-05	0.000206	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—FASN—ovarian cancer	1.15e-05	0.000206	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PTEN—ovarian cancer	1.14e-05	0.000205	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.14e-05	0.000205	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PPP2R1A—ovarian cancer	1.14e-05	0.000205	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.14e-05	0.000204	CbGpPWpGaD
Probenecid—ABCC5—Disease—CDKN1B—ovarian cancer	1.14e-05	0.000204	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SLC5A5—ovarian cancer	1.13e-05	0.000203	CbGpPWpGaD
Probenecid—ALB—Hemostasis—CAV1—ovarian cancer	1.12e-05	0.000202	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.12e-05	0.000202	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.12e-05	0.000201	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.11e-05	0.000198	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SLC2A1—ovarian cancer	1.09e-05	0.000196	CbGpPWpGaD
Probenecid—ABCC1—Disease—TERT—ovarian cancer	1.08e-05	0.000194	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CD—ovarian cancer	1.08e-05	0.000194	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.08e-05	0.000193	CbGpPWpGaD
Probenecid—ABCC5—Disease—CTNNB1—ovarian cancer	1.07e-05	0.000193	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CAV1—ovarian cancer	1.07e-05	0.000192	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.07e-05	0.000192	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—HRAS—ovarian cancer	1.06e-05	0.000191	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ABCB1—ovarian cancer	1.06e-05	0.00019	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—PIK3CA—ovarian cancer	1.06e-05	0.00019	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.05e-05	0.000189	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.05e-05	0.000189	CbGpPWpGaD
Probenecid—ABCC5—Disease—PTEN—ovarian cancer	1.05e-05	0.000188	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP1B1—ovarian cancer	1.04e-05	0.000188	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—TYMS—ovarian cancer	1.04e-05	0.000187	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.03e-05	0.000185	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CG—ovarian cancer	1.02e-05	0.000184	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.02e-05	0.000184	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.02e-05	0.000184	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—ovarian cancer	1.02e-05	0.000183	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CB—ovarian cancer	1.01e-05	0.000182	CbGpPWpGaD
Probenecid—ABCC1—Disease—CAV1—ovarian cancer	1e-05	0.00018	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	9.94e-06	0.000178	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.93e-06	0.000178	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—HRAS—ovarian cancer	9.77e-06	0.000175	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CG—ovarian cancer	9.75e-06	0.000175	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6ST—ovarian cancer	9.49e-06	0.00017	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—YAP1—ovarian cancer	9.46e-06	0.00017	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CB—ovarian cancer	9.42e-06	0.000169	CbGpPWpGaD
Probenecid—ALB—Metabolism—YAP1—ovarian cancer	9.41e-06	0.000169	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.37e-06	0.000168	CbGpPWpGaD
Probenecid—ABCC5—Disease—STAT3—ovarian cancer	9.35e-06	0.000168	CbGpPWpGaD
Probenecid—ABCC5—Disease—NRAS—ovarian cancer	9.33e-06	0.000167	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CAV1—ovarian cancer	9.32e-06	0.000167	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.31e-06	0.000167	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	9.27e-06	0.000166	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	9.26e-06	0.000166	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ABCB1—ovarian cancer	9.23e-06	0.000166	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.18e-06	0.000165	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.13e-06	0.000164	CbGpPWpGaD
Probenecid—ABCC1—Disease—APC—ovarian cancer	9.12e-06	0.000164	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—TYMS—ovarian cancer	9.06e-06	0.000163	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CD—ovarian cancer	8.99e-06	0.000161	CbGpPWpGaD
Probenecid—ABCC5—Disease—MAPK3—ovarian cancer	8.93e-06	0.00016	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.9e-06	0.00016	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.83e-06	0.000159	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTEN—ovarian cancer	8.75e-06	0.000157	CbGpPWpGaD
Probenecid—ABCC5—Disease—MYC—ovarian cancer	8.69e-06	0.000156	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYTB—ovarian cancer	8.66e-06	0.000156	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—AKT1—ovarian cancer	8.63e-06	0.000155	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ABCB1—ovarian cancer	8.6e-06	0.000154	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CD—ovarian cancer	8.57e-06	0.000154	CbGpPWpGaD
Probenecid—ABCC5—Disease—MAPK1—ovarian cancer	8.5e-06	0.000153	CbGpPWpGaD
Probenecid—ABCC5—Disease—EGFR—ovarian cancer	8.5e-06	0.000153	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	8.49e-06	0.000152	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—YAP1—ovarian cancer	8.45e-06	0.000152	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—TYMS—ovarian cancer	8.45e-06	0.000152	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CAV1—ovarian cancer	8.39e-06	0.000151	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.37e-06	0.00015	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.36e-06	0.00015	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—YAP1—ovarian cancer	8.24e-06	0.000148	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.23e-06	0.000148	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.19e-06	0.000147	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTEN—ovarian cancer	8.14e-06	0.000146	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PIK3CA—ovarian cancer	8.06e-06	0.000145	CbGpPWpGaD
Probenecid—ABCC5—Disease—KRAS—ovarian cancer	8.03e-06	0.000144	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CD—ovarian cancer	8.02e-06	0.000144	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.01e-06	0.000144	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CB—ovarian cancer	7.84e-06	0.000141	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—FASN—ovarian cancer	7.71e-06	0.000139	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—YAP1—ovarian cancer	7.7e-06	0.000138	CbGpPWpGaD
Probenecid—ALB—Metabolism—FASN—ovarian cancer	7.67e-06	0.000138	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CG—ovarian cancer	7.64e-06	0.000137	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.62e-06	0.000137	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.59e-06	0.000136	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.57e-06	0.000136	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.57e-06	0.000136	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.57e-06	0.000136	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC5A5—ovarian cancer	7.55e-06	0.000135	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CB—ovarian cancer	7.47e-06	0.000134	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	7.46e-06	0.000134	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.46e-06	0.000134	CbGpPWpGaD
Probenecid—ABCC5—Disease—PIK3CA—ovarian cancer	7.37e-06	0.000132	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.35e-06	0.000132	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC2A1—ovarian cancer	7.33e-06	0.000132	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CAV1—ovarian cancer	7.3e-06	0.000131	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC2A1—ovarian cancer	7.29e-06	0.000131	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL2—ovarian cancer	7.2e-06	0.000129	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.18e-06	0.000129	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.14e-06	0.000128	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB2—ovarian cancer	7.08e-06	0.000127	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1B1—ovarian cancer	7.03e-06	0.000126	CbGpPWpGaD
Probenecid—ABCC1—Disease—MTOR—ovarian cancer	6.99e-06	0.000125	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CB—ovarian cancer	6.99e-06	0.000125	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1B1—ovarian cancer	6.99e-06	0.000125	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—FASN—ovarian cancer	6.89e-06	0.000124	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—ovarian cancer	6.82e-06	0.000123	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CAV1—ovarian cancer	6.81e-06	0.000122	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.77e-06	0.000122	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—FASN—ovarian cancer	6.72e-06	0.000121	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CD—ovarian cancer	6.71e-06	0.000121	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.7e-06	0.00012	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CG—ovarian cancer	6.65e-06	0.000119	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.61e-06	0.000119	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—ovarian cancer	6.58e-06	0.000118	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDKN1B—ovarian cancer	6.56e-06	0.000118	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.54e-06	0.000117	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—ovarian cancer	6.53e-06	0.000117	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	6.5e-06	0.000117	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—ovarian cancer	6.45e-06	0.000116	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.41e-06	0.000115	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.38e-06	0.000115	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—FASN—ovarian cancer	6.28e-06	0.000113	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.27e-06	0.000113	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	6.23e-06	0.000112	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.2e-06	0.000111	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CG—ovarian cancer	6.2e-06	0.000111	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPP2R1A—ovarian cancer	6.2e-06	0.000111	CbGpPWpGaD
Probenecid—ABCC1—Disease—CTNNB1—ovarian cancer	6.2e-06	0.000111	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—ovarian cancer	6.18e-06	0.000111	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.18e-06	0.000111	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.17e-06	0.000111	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.12e-06	0.00011	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—ovarian cancer	6.12e-06	0.00011	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—ovarian cancer	6.04e-06	0.000108	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—ovarian cancer	6.04e-06	0.000108	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—ovarian cancer	6.02e-06	0.000108	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.96e-06	0.000107	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CB—ovarian cancer	5.85e-06	0.000105	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CD—ovarian cancer	5.85e-06	0.000105	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.84e-06	0.000105	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK3—ovarian cancer	5.79e-06	0.000104	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.79e-06	0.000104	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—ovarian cancer	5.75e-06	0.000103	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—ovarian cancer	5.74e-06	0.000103	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.72e-06	0.000103	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TYMS—ovarian cancer	5.68e-06	0.000102	CbGpPWpGaD
Probenecid—ALB—Metabolism—TYMS—ovarian cancer	5.65e-06	0.000101	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—ovarian cancer	5.62e-06	0.000101	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.56e-06	9.99e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.54e-06	9.94e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK1—ovarian cancer	5.51e-06	9.89e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CD—ovarian cancer	5.45e-06	9.79e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.43e-06	9.75e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—ovarian cancer	5.4e-06	9.7e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—ovarian cancer	5.39e-06	9.67e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—ovarian cancer	5.2e-06	9.34e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.16e-06	9.27e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK3—ovarian cancer	5.16e-06	9.26e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CB—ovarian cancer	5.1e-06	9.15e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—YAP1—ovarian cancer	5.08e-06	9.12e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TYMS—ovarian cancer	5.07e-06	9.11e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.07e-06	9.11e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—ovarian cancer	5.06e-06	9.08e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.05e-06	9.06e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—ovarian cancer	5.05e-06	9.06e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—ovarian cancer	5.02e-06	9.01e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TYMS—ovarian cancer	4.95e-06	8.89e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK1—ovarian cancer	4.91e-06	8.81e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—ovarian cancer	4.91e-06	8.81e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—ovarian cancer	4.78e-06	8.58e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CB—ovarian cancer	4.75e-06	8.53e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.71e-06	8.46e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—ovarian cancer	4.69e-06	8.42e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—ovarian cancer	4.64e-06	8.33e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TYMS—ovarian cancer	4.62e-06	8.3e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—ovarian cancer	4.62e-06	8.3e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAV1—ovarian cancer	4.58e-06	8.22e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—ovarian cancer	4.55e-06	8.18e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAV1—ovarian cancer	4.55e-06	8.17e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—ovarian cancer	4.42e-06	7.94e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—ovarian cancer	4.4e-06	7.91e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.37e-06	7.85e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.35e-06	7.81e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—ovarian cancer	4.26e-06	7.65e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.17e-06	7.49e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CG—ovarian cancer	4.15e-06	7.45e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—FASN—ovarian cancer	4.14e-06	7.43e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—ovarian cancer	4.1e-06	7.37e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAV1—ovarian cancer	4.09e-06	7.34e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.07e-06	7.31e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAV1—ovarian cancer	3.99e-06	7.16e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	3.96e-06	7.12e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—ovarian cancer	3.94e-06	7.08e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.93e-06	7.06e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.9e-06	7.01e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—ovarian cancer	3.9e-06	7.01e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—ovarian cancer	3.77e-06	6.77e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.77e-06	6.77e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAV1—ovarian cancer	3.73e-06	6.69e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.72e-06	6.68e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—ovarian cancer	3.72e-06	6.68e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.67e-06	6.58e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CD—ovarian cancer	3.65e-06	6.55e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.63e-06	6.52e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—ovarian cancer	3.57e-06	6.41e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.56e-06	6.39e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—ovarian cancer	3.48e-06	6.25e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.39e-06	6.09e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.34e-06	6.01e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.27e-06	5.88e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—ovarian cancer	3.24e-06	5.82e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.2e-06	5.74e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.19e-06	5.74e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CB—ovarian cancer	3.18e-06	5.71e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—ovarian cancer	3.11e-06	5.58e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.11e-06	5.58e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TYMS—ovarian cancer	3.05e-06	5.48e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.98e-06	5.36e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—ovarian cancer	2.91e-06	5.23e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—ovarian cancer	2.9e-06	5.2e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.85e-06	5.12e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.78e-06	5e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—ovarian cancer	2.76e-06	4.96e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—ovarian cancer	2.75e-06	4.93e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.6e-06	4.67e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—ovarian cancer	2.54e-06	4.56e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—ovarian cancer	2.47e-06	4.43e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAV1—ovarian cancer	2.46e-06	4.41e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—ovarian cancer	2.41e-06	4.32e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—ovarian cancer	2.37e-06	4.25e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—ovarian cancer	2.25e-06	4.04e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.24e-06	4.02e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.97e-06	3.53e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.95e-06	3.5e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—ovarian cancer	1.94e-06	3.48e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.74e-06	3.12e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.72e-06	3.08e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.7e-06	3.05e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—ovarian cancer	1.59e-06	2.86e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.59e-06	2.85e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—ovarian cancer	1.58e-06	2.84e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—ovarian cancer	1.48e-06	2.66e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—ovarian cancer	1.42e-06	2.55e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—ovarian cancer	1.39e-06	2.49e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—ovarian cancer	1.3e-06	2.33e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.05e-06	1.88e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—ovarian cancer	8.54e-07	1.53e-05	CbGpPWpGaD
